BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28149555)

  • 1. Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma.
    Parzen JS; Bates JE; Milano MT; Dhakal S
    J Thorac Dis; 2016 Dec; 8(12):3605-3613. PubMed ID: 28149555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    J Thorac Dis; 2012 Feb; 4(1):22-9. PubMed ID: 22295164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin's lymphoma: a systematic review and meta-analysis.
    Zhang M; Gao F; Peng L; Shen L; Zhao P; Ni B; Hou J; Huang H
    Cancer Cell Int; 2021 Oct; 21(1):524. PubMed ID: 34627251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
    Lin L; Wang D; Chen H
    PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
    Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
    J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
    Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
    Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related Acute Myeloid Leukemia in Non-Hodgkin Lymphoma Survivors: Risk, Survival Outcomes and Prognostic Factor Analysis.
    Joshi U; Bhattarai A; Gaire S; Budhathoki P; Agrawal V; Subedi R; Poudyal BS; Dhakal P; Sham R; Bhatt VR
    Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):79-87. PubMed ID: 37581464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.
    Lu S; Yu Y; Chen Z; Ye X; Li Z; Niu X
    Lung; 2015 Oct; 193(5):805-14. PubMed ID: 26119960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis.
    Jia B; Zheng Q; Qi X; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Shi Y; Du F; Wang J; Chi Y; Zhai X; Wang Z
    Thorac Cancer; 2019 Mar; 10(3):459-471. PubMed ID: 30628193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
    Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
    Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
    Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
    Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors.
    Ocier K; Abdelaziz S; Kim S; Rowe K; Snyder J; Deshmukh V; Newman M; Fraser A; Smith K; Porucznik CA; Shoaf K; Stanford JB; Lee CJ; Hashibe M
    Cancer Med; 2021 Jun; 10(12):4117-4126. PubMed ID: 33979029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.